Institute of Immunology & Immunotherapy University of Birmingham, Birmingham, UK.
NIHR Wellcome Trust Clinical Research Facilities University Hospitals Birmingham NHS Trust, University of Birmingham, Birmingham, UK.
Inflamm Bowel Dis. 2021 Oct 20;27(11):1719-1730. doi: 10.1093/ibd/izab059.
Endoscopic and histological remission are both important treatment goals in patients with ulcerative colitis (UC). We aimed to define cellular architecture, expression of molecular markers, and their correlation with endoscopic scores assessed by ultra-high magnification endocytoscopy (ECS) and histological scores.
Patients with UC (n = 29) were prospectively recruited. The correlation among ECS score (ECSS), Mayo endoscopic score (MES), and histological scores were determined. Area under curve were plotted to determine the best thresholds for ECSS that predicted histological remission by Robarts (RHI) and Nancy Histological Index (NHI).Soluble analytes relevant to inflammation were measured in serum and mucosal culture supernatants using ProcartaPlex Luminex assays and studied by partial least square discriminant analysis and logistic model. Mucosal RNA sequencing and bioinformatics analysis were performed to define differentially expressed genes/pathways.
Endocytoscope scoring system correlated strongly with RHI (r = 0.89; 95% CI, 0.51-0.98) and NHI (r = 0.86; 95% CI, 0.42-0.98) but correlated poorly with MES (r = 0.28; 95% CI, 0.27-0.70). We identified soluble brain-derived neurotrophic factors (BDNF), macrophage inflammatory proteins (MIP-1 α) and soluble vascular cell adhesion molecule 1 (sVCAM-1) predicted histological remission. Mucosal biopsy cultures also identified sVCAM-1 associated with healed mucosa. RNA-seq analysis identified gene expressions shared between ECSS, RHI, or NHI defined healing. A number of gene expressions and pathways were identified including inflammation and metabolic and tumor suppressors that discriminated healed from nonhealed mucosa.
Endocytoscopy represents an interesting tool that may sit between endoscopy and histology-but closer to the latter-identifying gene expression markers and pathways that are also identified by histology.
内镜和组织学缓解都是溃疡性结肠炎(UC)患者的重要治疗目标。我们旨在定义细胞结构、分子标志物的表达及其与超高倍放大内镜(ECS)评估的内镜评分和组织学评分的相关性。
前瞻性招募了 29 例 UC 患者。确定 ECS 评分(ECSS)、Mayo 内镜评分(MES)和组织学评分之间的相关性。绘制曲线下面积以确定 ECSS 预测 Robarts (RHI)和 Nancy 组织学指数(NHI)组织学缓解的最佳阈值。使用 ProcartaPlex Luminex 测定法测量血清和黏膜培养上清液中与炎症相关的可溶性分析物,并通过偏最小二乘判别分析和逻辑模型进行研究。进行黏膜 RNA 测序和生物信息学分析以定义差异表达的基因/途径。
内诊镜评分系统与 RHI(r = 0.89;95%CI,0.51-0.98)和 NHI(r = 0.86;95%CI,0.42-0.98)高度相关,但与 MES(r = 0.28;95%CI,0.27-0.70)相关性差。我们鉴定了可溶性脑源性神经营养因子(BDNF)、巨噬细胞炎性蛋白(MIP-1α)和可溶性血管细胞黏附分子 1(sVCAM-1),它们可预测组织学缓解。黏膜活检培养物也鉴定了与愈合黏膜相关的 sVCAM-1。RNA-seq 分析鉴定了与 ECSS、RHI 或 NHI 定义的愈合相关的基因表达。确定了许多基因表达和途径,包括炎症、代谢和肿瘤抑制因子,这些基因表达和途径可区分愈合和非愈合黏膜。
内诊镜代表了一种有趣的工具,它可能位于内镜和组织学之间,但更接近后者,可识别组织学也能识别的基因表达标志物和途径。